Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Eloxatin Plus Gemcitabine Chemotherapy for Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | April 1, 2004 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00859469 |
| Study Type: | Interventional |
| Intervention: | Drug: Oxaliplatin/Gemcitabine |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Columbia University |
| Ages: | Adult|Senior |
| Enrollment: | 29 |
| Funded By: | Other |
| First Received: | March 9, 2009 |
| End Date: | April 1, 2011 |
| Last Updated: | January 12, 2011 |
| Last Verified: | January 1, 2011 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
